Free Trial

Curaleaf (OTCMKTS:CURLF) Trading Up 24% - Still a Buy?

Curaleaf logo with Medical background

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares traded up 24% on Monday . The company traded as high as $1.24 and last traded at $1.24. 678,026 shares traded hands during mid-day trading, an increase of 23% from the average session volume of 551,082 shares. The stock had previously closed at $1.00.

Curaleaf Trading Up 13.2%

The company has a debt-to-equity ratio of 1.08, a current ratio of 1.41 and a quick ratio of 0.70. The stock has a market capitalization of $964.11 million, a PE ratio of -4.64 and a beta of 0.62. The stock's 50 day simple moving average is $0.91 and its two-hundred day simple moving average is $1.05.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.07). Curaleaf had a negative net margin of 17.37% and a negative return on equity of 14.12%. On average, sell-side analysts expect that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines